{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:07:42Z","timestamp":1780070862369,"version":"3.54.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T00:00:00Z","timestamp":1361923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Among Influenza neuraminidase inhibitors (NAIs), oseltamivir corresponds to the most widely used agent to treat influenza disease. However since 2001, several cases of resistance to NAIs have been reported for circulating seasonal A(H1N1) Influenza viruses. A direct resistance mechanism may be invoked, involving critical mutations in the viral NA gene that prevent the drug binding to its target. Same phenomenon is reported for adamantanes drugs and mutations in the M2 channel protein gene of Influenza viruses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Reverse-Transcription\/Restriction Fragment Length Polymorphism (RT-PCR\/RFLP) method, phenotypic testing for oseltamivir resistance, and sequencing of NA, HA and M2 genes were used in this study. Phylogenetic analyses were performed using BioEdit and Mega 5 softwares for alignment of sequences and phylogenetic trees building respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using a simple RT-PCR\/RFLP method, we found that the 86 seasonal A(H1N1) isolates from 2008 bear the oseltamivir resistance-associated mutation (H274Y) in the NA gene. In contrast all isolates isolated in Senegal in 2007 were sensitive to oseltamivir. These results were first confirmed by finding high IC50 values using a phenotypic testing for oseltamivir resistance, and secondly by sequencing the whole NA gene. Regarding M2 gene, no mutation associated to adamantanes resistance was characterized of the isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The present work provides evidence of circulation of drug-resistant seasonal A(H1N1) viruses during the 2008 influenza season (July to September) in Senegal. The results are in favor of multiple introductions of oseltamivir resistant viruses (ORV) A(H1N1) in Senegal.<\/jats:p><jats:p>Phylogenetic analyses of isolates with complete sequences of N1 and HA1 genes showed that they belong to clade 2B and suggest sequential introductions in Africa.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2334-13-106","type":"journal-article","created":{"date-parts":[[2013,2,27]],"date-time":"2013-02-27T07:14:11Z","timestamp":1361949251000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal"],"prefix":"10.1186","volume":"13","author":[{"given":"Ndongo","family":"Dia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mbayame N","family":"Niang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadiya A","family":"Diadhiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah G","family":"Goudiaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdourahmane","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy","family":"Kiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mady","family":"B\u00e2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousmane M","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,27]]},"reference":[{"key":"2320_CR1","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1128\/AAC.37.7.1473","volume":"37","author":"JM Woods","year":"1993","unstructured":"Woods JM, Bethell RC, Coates JAV, Healy N, Hiscox SA, Pearson BA, Ryan DM, Ticehurst J, Tilling J, Walcot SMAND, Penn CR: 4-Guanidino-2, 4-dideoxy-2, 3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (NA) and of growth of a wide range of infuenza A and B viruses in vitro. Antimicrob Agents Chemother. 1993, 37: 1473-1479. 10.1128\/AAC.37.7.1473.","journal-title":"Antimicrob Agents Chemother"},{"key":"2320_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1021\/ja963036t","volume":"119","author":"CU Kim","year":"1997","unstructured":"Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG, Stevens RC: Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc. 1997, 119: 681-690. 10.1021\/ja963036t.","journal-title":"J Am Chem Soc"},{"key":"2320_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/00006454-200102000-00002","volume":"20","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D, Mills RG, Ward P: Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001, 20: 127-133. 10.1097\/00006454-200102000-00002.","journal-title":"Pediatr Infect Dis J"},{"key":"2320_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.virusres.2004.02.033","volume":"103","author":"BA Mungall","year":"2004","unstructured":"Mungall BA, Xu X, Klimov A: Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons. Virus Res. 2004, 103: 195-197. 10.1016\/j.virusres.2004.02.033.","journal-title":"Virus Res"},{"issue":"1416","key":"2320_CR5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1098\/rstb.2001.1002","volume":"356","author":"NA Roberts","year":"2001","unstructured":"Roberts NA: Treatment of influenza with neuraminidase inhibitors: virological implications. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29, 356 (1416): 1895-1897.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"2320_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0166-3542(02)00053-0","volume":"55","author":"JA Ives","year":"2002","unstructured":"Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA: The H274Y mutation in the influenza A\/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Res. 2002 Aug, 55 (2): 307-317. 10.1016\/S0166-3542(02)00053-0.","journal-title":"Antiviral Res"},{"key":"2320_CR7","volume-title":"Timeline for the emergence of oseltamivir resistant influenza A(H1N1) 2007-8 [cited 2008 November 21]","author":"ECDC","year":"2007","unstructured":"ECDC: Timeline for the emergence of oseltamivir resistant influenza A(H1N1) 2007-8 [cited 2008 November 21]. 2007, Available from http:\/\/ecdc.europa.eu\/en\/healthtopics\/documents\/0810_seasonal_influenza_avr_timeline.pdf, -8 [cited 2008 November 21]"},{"key":"2320_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3201\/eid1502.081031","volume":"15","author":"SH Hauge","year":"2009","unstructured":"Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O: Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis. 2009, 15: 155-162. 10.3201\/eid1502.081031.","journal-title":"Emerg Infect Dis"},{"key":"2320_CR9","doi-asserted-by":"crossref","first-page":"ii 8026","DOI":"10.2807\/ese.13.05.08026-en","volume":"13","author":"A Lackenby","year":"2008","unstructured":"Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, Zambon MC: Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe. Eur Surveill. 2008, 13: ii 8026-","journal-title":"Eur Surveill"},{"key":"2320_CR10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteel J, Hay A, Zambon M: Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 Season. Emerg Infect Dis. 2009, 15: 552-560. 10.3201\/eid1504.081280.","journal-title":"Emerg Infect Dis"},{"key":"2320_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","volume":"83","author":"AC Hurt","year":"2009","unstructured":"Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D\u2019Souza H, Komadina N, Shaw R, Kelso A, Barr iG: Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res. 2009, 83: 90-93. 10.1016\/j.antiviral.2009.03.003.","journal-title":"Antiviral Res"},{"issue":"11","key":"2320_CR12","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3201\/eid1411.080958","volume":"14","author":"TG Besselaar","year":"2008","unstructured":"Besselaar TG, Naidoo D, Buys A, Gregory V, McAnerney J, Manamela JM, Blumberg L, Schoub BD: Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa [letter]. Emerg Infect Dis. 2008, 14 (11): 1809-1810. 10.3201\/eid1411.080958.","journal-title":"Emerg Infect Dis"},{"key":"2320_CR13","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1128\/jvi.67.9.5585-5594.1993","volume":"67","author":"C Wang","year":"1993","unstructured":"Wang C, Takeuchi K, Pinto LH, Lamb RA: Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol. 1993, 67: 5585-5594.","journal-title":"J Virol"},{"issue":"suppl B","key":"2320_CR14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/18.Supplement_B.19","volume":"18","author":"AJ Hay","year":"1986","unstructured":"Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH: Molecular basis of resistance of influenzaAviruses to amantadine. J Antimicrob Chemother. 1986, 18 (suppl B): 19-29.","journal-title":"J Antimicrob Chemother"},{"key":"2320_CR15","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/jvi.62.5.1508-1512.1988","volume":"62","author":"RB Belshe","year":"1988","unstructured":"Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ: Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J Virol. 1988, 62: 1508-1512.","journal-title":"J Virol"},{"key":"2320_CR16","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4269\/ajtmh.2000.62.639","volume":"62","author":"A Dosseh","year":"2000","unstructured":"Dosseh A, Ndiaye K, Spiegel A, Sagna M, Mathiot C: Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998. Am J Trop Med Hyg. 2000, 62: 639-643.","journal-title":"Am J Trop Med Hyg"},{"key":"2320_CR17","volume-title":"WHO Manual on Animal influenza Diagnosis and Surveillance","author":"World Health Organization","year":"2002","unstructured":"World Health Organization: WHO Manual on Animal influenza Diagnosis and Surveillance. 2002, Geneva: World Health Organization"},{"key":"2320_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2009.01.004","volume":"82","author":"L Guo","year":"2009","unstructured":"Guo L, Garten RJ, Foust AS, Sessions WM, Okomo-Adhiambo M, Gubareva LV, Klimov AI, Xu X: Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR\/restriction fragment length polymorphism assay. Antiviral Res. 2009, 82: 1-10.1016\/j.antiviral.2008.12.015.","journal-title":"Antiviral Res"},{"key":"2320_CR19","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol Biol Evol. 2011, 28: 2731-2739. 10.1093\/molbev\/msr121.","journal-title":"Mol Biol Evol"},{"key":"2320_CR20","first-page":"95","volume":"41","author":"TA Hall","year":"1999","unstructured":"Hall TA: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95\/98\/NT. Nucl Acids Symp. 1999, 41: 95-98.","journal-title":"Nucl Acids Symp"},{"issue":"1","key":"2320_CR21","first-page":"29","volume":"82","author":"Y Abed","year":"2005","unstructured":"Abed Y, Goyette N, Boivin G: Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 49, 556\u2013559. Antiviral Res. 2005, 82 (1): 29-33.","journal-title":"Antiviral Res"},{"key":"2320_CR22","volume-title":"Sentinel surveillance for influenza in Senegal, 1996-2009","author":"MN Niang","year":"49122","unstructured":"Niang MN, Dosseh A, NDiaye K, Sagna M, Victoria Gregory V, Deborah G, Alan Hay A, Diop OM: Sentinel surveillance for influenza in Senegal, 1996-2009. 49122, In press JID supplement (manuscript number: 49122)"},{"key":"2320_CR23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/135965350701200S04.1","volume":"12","author":"FY Aoki","year":"2007","unstructured":"Aoki FY, Boivin G, Roberts N: Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther. 2007, 12: 603-616.","journal-title":"Antivir Ther"},{"key":"2320_CR24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","volume":"364","author":"M Kiso","year":"2004","unstructured":"Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, Hayden FG, Sugaya N, Kawaoka Y: Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004, 364: 759-765. 10.1016\/S0140-6736(04)16934-1.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2320_CR25","doi-asserted-by":"publisher","first-page":"i5","DOI":"10.1093\/jac\/dki018","volume":"55","author":"P Ward","year":"2005","unstructured":"Ward P, Small I, Smith J, Suter P, Dutkowski R: Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005, 55 (Suppl 1): i5-i21.","journal-title":"J Antimicrob Chemother"},{"key":"2320_CR26","first-page":"156","volume":"80","author":"Neuraminidase Inhibitor Susceptibility Network","year":"2005","unstructured":"Neuraminidase Inhibitor Susceptibility Network: Use of influenza antivirals during 2003\u20132004 and monitoring of neuraminidase inhibitor resistance. Wkly Epidemiol Rec. 2005, 80: 156-","journal-title":"Wkly Epidemiol Rec"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-106\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-106.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T14:35:21Z","timestamp":1715006121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,27]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2320"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-106","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,27]]},"assertion":[{"value":"12 May 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"106"}}